OptiBiotix to bring cholesterol reduction product to India with new agreement
The agreement was signed with Akums Drugs and Pharmaceuticals Ltd, a leading contract manufacturer of food and drug supplements in India
Company
LON:OPTI
OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing and commercialising technologies that modulate the human microbiome – the collective genome of the microbes in the body – the company identifies and develops prebiotic formulations and compounds for use in food ingredients and supplements that can impact on human physiology and metabolism, deriving potential health benefits.
574 stories · page 4 of 6
The agreement was signed with Akums Drugs and Pharmaceuticals Ltd, a leading contract manufacturer of food and drug supplements in India
Investments and investor services
The UK blue-chip benchmark closed around 11 points higher at 7,334..
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London on Tuesday
OptiBiotix will show off new product concepts for its SlimBiome weight loss ingredient, as well as the latest data from human studies of its LPLDL cholesterol and blood pressure-reducing probiotic
FTSE 100 closed 1.39 points lower at 7,565, while FTSE 250 went the other way
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of the biggest risers and fallers in London on Tuesday.
OptiBiotix said it can confirm it is in discussions with Seed Heath to agree commercial terms for the use of its LP-LDL strain in Seed's products in preparation for a May launch in the US
Investments and investor services
Poor manufacturing stats raise worries over the British economy, the PMI measure for April was the lowest for 17-months..
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Tuesday
The AIM-listed firm said the agreement extends SlimBiome’s commercial reach into new application areas where Cambridge Commodities Ltd has specific sector expertise, such as sports, health & wellbeing and the ingredients sectors
Stocks consolidated gains at the death with bid stock Shire the best performing blue-chip
In a note to clients initiating coverage on SkinBio, the joint ‘house’ broker noted that, as the skin microbiome group operates in a new therapeutic area, there is little market data in the sector
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
MYCELX now expects full-year revenues to be in the range of US$16-17mln after the new order and equipment sale
The AIM-listed firm said Steven Riley will lead the development of the Optibiotix online presence as another revenue generating business in its own right
Shire shares ended 5.89% up as the group received and rejected a takeover approach from Japan's Takeda Pharma
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Oil prices have recovered over the past year which has led to companies setting up more rigs; good news for Enteq, an oilfield services provider
Trigen Pharma will distribute and commercialise OptiBiotix’s cholesterol- and blood pressure-reducing CholBiome products in Pakistan
Investments and investor services
FTSE 100 gained support from higher metals prices and a slide in sterling on Wednesday to close higher
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Thursday.
The obesity and cholesterol management company said that the global sweetener market, currently dominated by sugar, is forecast to reach US$112bln by 2020
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Tuesday
OptiBiotix said: “The overall aim is to build revenues within each division to between £5mln-£10mln per annum over the forthcoming years”
In the currency markets, the pound shed 0.17% against the Euro, and lost 0.46% against the US dollar
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The AIM-listed obesity and cholesterol management company said that the partnership would extend the application of its SlimBiome® technology in breakfast cereals and bakery products
Investments and investor services
The premier UK blue-chip exchange added around 45 points at 7,203, while FTSE 250 also stormed higher, up 193 points at 19,968.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Tuesday
The agreement will allow Fine Foods to promote specific formulations and presentations containing the OptiBiotix's LPLDL strain to customers seeking to reduce cholesterol, blood pressure and cardiovascular risk
The UK premier index added 0.43% on the day, while FTSE 250 added over 123 points at 19,690.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Defenx is not the first software company to invoice customers only to see the orders delayed
The cancellation of its share premium account means the company, which develops compounds to tackle obesity, high cholesterol and diabetes, can distribute dividends when it deems it appropriate to do so
Investments and investor services
The Footsie may have mainly traded sideways throughout the day but there have been some notable movements among blue-chips.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the day's big movers, such as Altyn, Thor Mining, N Brown, and Pets at Home
The company is developing sweet, natural, healthy fibres which are not digested in the human gut, and are therefore calorie-free
Investments and investor services
The pound is down 0.21% against the Euro and off 0.04% against the US dollar at the time of writing
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of the top risers and fallers in London today.
The poster and verbal exposition will focus on OptiBiotix's ability to identify and develop targeted prebiotics
Archive
The fall-out from the Carillion collapse continued, the US market saw more volatility, meanwhile, Bitcoin continued to slump testing US$10,000.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The trading update was short and sweet. Liberum responded by increasing its target price.
Cereal Ingredients Inc will incorporate SlimBiome into their range of cereal and protein-based particulates which are used in food products such as cakes, cookies and crackers
Robert Walters sprang a pleasant surprise on the market with an unscheduled trading update.
High blood pressure, or hypertension, hardens the arteries and increases the risk of heart disease
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Real estate investment trust LXB Retail Properties enjoyed a rare moment in the sun while PCI Pal hailed some impressive contract wins
Former Express Dairies and Arla Foods chief executive Neil Davidson will take over from Adam Reynolds next month
The company is a pioneer in the human microbiome, which is essentially the bacteria that inhabits the gut and skin
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the biggest risers and fallers in London on Monday
Rather than making regular cash pay-outs, the company wants to be able to sanction a “dividend in specie” that would allow it to distribute its holding in SkinBioTherapeutics
The award recognised the innovation and scientific credibility behind SlimBiome, said chief executive Stephen O'Hara
Slimbiome has been short-listed for best functional ingredient for health and wellbeing in the upcoming Food Matters Live
Archive
A look at some of the day's highlights from the Proactive Investors newswire
Knighton’s tehcnology will make SlimBiome easier to dissolve and enhancing its ease of use, flavour and mouthfeel
On Tuesday PureTech said affiliate Vedanta Biosciences had in-licensed microbiome-derived cancer immunotherapies based on live biotherapeutics
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The FTSE 100 closed out Thursday up around 67 points at 7,555.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London today
The deal is with Knighton Foods, a supplier of powdered products to supermarkets and High Street coffee houses
Investments and investor services
At around 3.55pm, the UK blue chip index was up 5 points to 7,498
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London today
“These presentations at major international conferences are important steps in establishing the scientific maturity and credibility of our technologies"
The UK blue chip index closed down over 39 points at 7.486.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Galenicum is one of Spain's leading pharmaceutical groups with an annual turnover of €100mln
The UK blue chip index closed its account on Tuesday up 2.09 at 7,526.
The failures of these drugs has sparked interest in a possible combination with LP-LDL said Stephen O'Hara, Optibiotix's chief executive
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Peter Allen will not be going back to the Future board room after February's AGM
The event was attended by 16,500 ingredient buyers and suppliers from the supplement, beverage, functional food, personal care and sports nutrition industries
Not much happening among the blue-chips but Image Scan and Future were among the big movers in the small caps sector
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The new formulation is a single homogenous product, a development that reduces separation in transport
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the main news driven risers and fallers at 3.40pm…
It's just a memorandum of understanding at the moment but the alliance looks an interesting one for OptiBiotix, as it takes it into the field of psycho-biotics – where bacteria in the gut communicates with the brain
The heavyweight dragged on the FTSE 100, which closed down 20.99 points
OptiBiotix is a pioneer in the human microbiome, which is essentially the bacteria that inhabits the gut and skin
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The agreement gives Tata the exclusive rights to produce a sugar from OptiBiotix’s LP-LDL probiotic strain